A series of potent HIV-1 protease inhibitors with a lipophilic adamantyl P1 ligand have been designed, synthesized and evaluated. We have developed an enantioselective synthesis of adamantane-derived hydroxyethylamine isostere utilizing Sharpless asymmetric epoxidation as the key step. Various inhibitors incorporating P1-adamanylmethyl in combination with P2-ligands such as 3-(R)-THF, 3-(S)-THF, bis-THF and THF-THP were examined. The S1′ pocket was also probed with phenyl and phenylmethyl ligands. Inhibitor 15d, with an isobutyl P1′ ligand and a bis-THF P2 ligand proved to be the most potent of the series. The cLogP value of inhibitor 15d is impoved compared to inhibitor 2 with a phenylmethyl P1-ligand. X-ray structural studies of 15d, 15h and 15i with HIV-1 protease complexes revealed molecular insight into the inhibitor-protein interaction.